$20.73
-0.86-3.98%
At close: -
$20.95
0.221.06%
After Hours: 7:24 PM EDT
Comments
Loading...
Denali Therapeutics (DNLI) Forecast
NewsEarningsDenali Therapeutics (DNLI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestDenali Therapeutics (NASDAQ:DNLI) Stock Quotes, Forecast and News Summary
Denali Therapeutics Stock (NASDAQ: DNLI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Denali Therapeutics (DNLI) stock?
You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.
Who are Denali Therapeutics (DNLI) competitors?
Other companies in Denali Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA) and Protagonist Therapeutics (NASDAQ:PTGX).
What is the forecast, or price target, for Denali Therapeutics (DNLI) stock?
Denali Therapeutics has a consensus price target of $41.95.
What is the current price for Denali Therapeutics (DNLI)?
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $20.95 last updated February 21, 2025 at 7:24 PM EST.
Does Denali Therapeutics (DNLI) pay a dividend?
There are no upcoming dividends for Denali Therapeutics.
When is Denali Therapeutics (NASDAQ:DNLI) reporting earnings?
Denali Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Denali Therapeutics (DNLI) going to split?
There is no upcoming split for Denali Therapeutics.
What sector and industry does Denali Therapeutics (DNLI) operate in?
Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.